Skip to main content Skip to footer
American Family Children's Hospital
Saurabh A. Rajguru, MD close
Saurabh A. Rajguru, MD

New Patients

Need help selecting a primary care doctor? Contact the Welcome Center for personal assistance.

For Referring Physicians

How to refer a patient

Saurabh A. Rajguru, MD Print Friendly Page

Faculty, University of Wisconsin School of Medicine and Public Health

Dr. Rajguru is a clinical assistant professor of medicine within the division of hematology/oncology at the University of Wisconsin School of Medicine and Public Health, Madison, WI.  He received his medical degree at the University of Illinois at Chicago, Chicago, IL. He went on to postgraduate internship, residency and fellowship training at University of Wisconsin Hospital and Clinics, Madison, WI. Dr. Rajguru is board-certified in internal medicine, medical oncology and hematology and a member of The American Society of Hematology and The American Society of Clinical Oncology.



Medical Oncology

Hematology (Leukemia, Lymphoma and Multiple Myeloma)

Hematology (non cancer)


1 S. Park Clinic
(608) 287-2552 | (888) 703-2778 | Map
Beaver Dam Community Hospital
(920) 887-4105 | (888) 703-2778 | Map

Hospital Affiliation(s)

University Hospital
UnityPoint Health - Meriter

UW School of Medicine and Public Health

Department of Medicine

Professional Certifications and Education

Board Certification Hematology
Internal Medicine
Medical Oncology
Fellowship University of Wisconsin Hospital and Clinics, Madison, WI
Residency University of Wisconsin Hospital and Clinics, Madison, WI
Medical School University of Illinois at Chicago College of Medicine, Chicago, IL

Medical interpreters are available to help patients communicate with hospital and clinic staff. For more information, please contact interpreter services at (608) 262-9000.

Dr. Rajguru’s clinical and research interests are in malignant hematology, specifically hodgkin and non-hodgkin lymphomas and chronic lymphocytic leukemia (CLL).

PubMed Articles
Landsburg DJ Falkiewicz MK Petrich AM Chu BA Behdad A Li S Medeiros LJ Cassaday RD Reddy NM Bast MA Vose JM Kruczek KR Smith SE Patel P Hernandez-Ilizaliturri F Karmali R Rajguru S Yang DT Maly JJ Blum KA Zhao W Vanslambrouck C Nabhan C Sole rearrangement but not amplification of MYC is associated with a poor prognosis in patients with diffuse large B cell lymphoma and B cell lymphoma unclassifiable. Br J Haematol . 2016 Nov;175(4):631-640
[PubMed ID: 27469075]
Jin N Lubner SJ Mulkerin DL Rajguru S Carmichael L Chen H Holen KD LoConte NK A Phase II Trial of a Histone Deacetylase Inhibitor Panobinostat in Patients With Low-Grade Neuroendocrine Tumors. Oncologist . 2016 Jul;21(7):785-6
[PubMed ID: 27261467]
Rajguru S Kahl BS Mantle cell lymphoma-management in evolution. Chin Clin Oncol . 2015 Mar;4(1):8
[PubMed ID: 25841715]
Petrich AM Gandhi M Jovanovic B Castillo JJ Rajguru S Yang DT Shah KA Whyman JD Lansigan F Hernandez-Ilizaliturri FJ Lee LX Barta SK Melinamani S Karmali R Adeimy C Smith S Dalal N Nabhan C Peace D Vose J Evens AM Shah N Fenske TS Zelenetz AD Landsburg DJ Howlett C Mato A Jaglal M Chavez JC Tsai JP Reddy N Li S Handler C Flowers CR Cohen JB Blum KA Song K Sun HL Press O Cassaday R Jaso J Medeiros LJ Sohani AR Abramson JS Impact of induction regimen and stem cell transplantation on outcomes in double-hit lymphoma: a multicenter retrospective analysis. Blood . 2014 Oct 9;124(15):2354-61
[PubMed ID: 25161267]
Rajguru S Kahl BS Emerging therapy for the treatment of mantle cell lymphoma. J Natl Compr Canc Netw . 2014 Sep;12(9):1311-8; quiz 1318
[PubMed ID: 25190697]
Rajguru S Kristinsdottir T Eickhoff J Peterson C Meyer CM Traynor AM Kahl BS Yttrium 90-ibritumomab tiuxetan plus rituximab maintenance as initial therapy for patients with high-tumor-burden follicular lymphoma: a Wisconsin Oncology Network study. Clin Adv Hematol Oncol . 2014 Aug;12(8):509-15
[PubMed ID: 25356575]